Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Widschwendter

Showing results (141-150 of 175) with videos related to

Pageof 18
Sort By:
Plos Medicine|November 23, 2013
Role of DNA methylation and epigenetic silencing of HAND2 in endometrial cancer developmentAllison Jones, Andrew E Teschendorff, Quanxi Li, et al.
Genome Research|March 12, 2010
Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancerAndrew E Teschendorff, Usha Menon, Aleksandra Gentry-Maharaj, et al.
International Journal of Cancer|December 19, 2022
The WID-EC test for the detection and risk prediction of endometrial cancerJames E Barrett, Allison Jones, Iona Evans, et al.
Nature Communications|February 2, 2022
The WID-BC-index identifies women with primary poor prognostic breast cancer based on DNA methylation in cervical samplesJames E Barrett, Chiara Herzog, Allison Jones, et al.
Environmental Epidemiology (Philadelphia, Pa.)|December 15, 2021
Human exposome assessment platformRoxana Merino Martinez, Heimo Müller, Stefan Negru, et al.
Genome Medicine|June 14, 2022
Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy womenThomas E Bartlett, Iona Evans, Allison Jones, et al.
Nature Reviews. Clinical Oncology|February 28, 2018
Epigenome-based cancer risk prediction: rationale, opportunities and challengesMartin Widschwendter, Allison Jones, Iona Evans, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 2, 2020
Targeting progesterone signaling prevents metastatic ovarian cancerOlga Kim, Eun Young Park, Sun Young Kwon, et al.
NPJ Breast Cancer|June 25, 2026
Individualised progesterone receptor modulator prevention strategies for triple-negative breast cancer in BRCA1 pathogenic variant carriersMartin Widschwendter, Rita Schmutzler, Nora Pashayan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 15, 2023
Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous CarcinomaChen Wang, Matthew S Block, Julie M Cunningham, et al.
Pageof 18

Showing results (141-150 of 175) with videos related to

Sort By:
Pageof 18
Plos Medicine|November 23, 2013
Role of DNA methylation and epigenetic silencing of HAND2 in endometrial cancer developmentAllison Jones, Andrew E Teschendorff, Quanxi Li, et al.
Genome Research|March 12, 2010
Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancerAndrew E Teschendorff, Usha Menon, Aleksandra Gentry-Maharaj, et al.
International Journal of Cancer|December 19, 2022
The WID-EC test for the detection and risk prediction of endometrial cancerJames E Barrett, Allison Jones, Iona Evans, et al.
Nature Communications|February 2, 2022
The WID-BC-index identifies women with primary poor prognostic breast cancer based on DNA methylation in cervical samplesJames E Barrett, Chiara Herzog, Allison Jones, et al.
Environmental Epidemiology (Philadelphia, Pa.)|December 15, 2021
Human exposome assessment platformRoxana Merino Martinez, Heimo Müller, Stefan Negru, et al.
Genome Medicine|June 14, 2022
Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy womenThomas E Bartlett, Iona Evans, Allison Jones, et al.
Nature Reviews. Clinical Oncology|February 28, 2018
Epigenome-based cancer risk prediction: rationale, opportunities and challengesMartin Widschwendter, Allison Jones, Iona Evans, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 2, 2020
Targeting progesterone signaling prevents metastatic ovarian cancerOlga Kim, Eun Young Park, Sun Young Kwon, et al.
NPJ Breast Cancer|June 25, 2026
Individualised progesterone receptor modulator prevention strategies for triple-negative breast cancer in BRCA1 pathogenic variant carriersMartin Widschwendter, Rita Schmutzler, Nora Pashayan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 15, 2023
Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous CarcinomaChen Wang, Matthew S Block, Julie M Cunningham, et al.
Pageof 18